Please login to the form below

Not currently logged in
Email:
Password:

Pfizer recalls contaminated IV drugs

Company recalls antibiotics and anti-emetics manufactured by Claris Laboratories due to floating matter and concerns over sterility

Pfizer has recalled batches of the antibiotics metronidazole and ciprofloxacin and the anti-emetic ondansetron after the manufacturer, India-based Claris Laboratories, discovered contamination in the plastic intravenous (IV) bags containing the drugs. All contaminated products are believed to have been made on the same production line.

The FDA website has reported that the white substance floating in a bag of metronidazole was identified by microbiological analysis as Cladosporium mould. Another bag, containing ondansetron, is currently under analysis.

Administering non-sterile products intravenously could result in potentially life-threatening infections, particularly in immunocompromised patients.

The products have only been distributed in the US. Under FDA guidance, Pfizer has recalled all products already distributed and has halted distribution of the remaining products affected by the recall: of the approximately 1.7m bags received from Claris, approximately 80 per cent, or 1.3m, remain in Pfizer's control.

7th June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics